Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Kingworld Medicines Group Ltd. ( (HK:1110) ) just unveiled an announcement.
Kingworld Medicines Group Ltd. announced the successful passing of all resolutions at its Annual General Meeting held on May 29, 2025. Key resolutions included the adoption of financial statements, declaration of a final dividend, re-election of directors, and granting of mandates for share issuance and repurchase. The unanimous approval of these resolutions, with a high shareholder turnout, underscores strong shareholder support and positions the company for continued strategic growth.
More about Kingworld Medicines Group Ltd.
Kingworld Medicines Group Ltd. operates in the pharmaceutical industry, focusing on the production and distribution of medicines and health products. The company is primarily engaged in providing high-quality pharmaceutical products to meet market demands.
Average Trading Volume: 1,278,655
Technical Sentiment Signal: Buy
Current Market Cap: HK$363.9M
See more data about 1110 stock on TipRanks’ Stock Analysis page.